RAGHX Performance — Virtus KAR Health Sciences Fund, Class A
Data updated: 2026-09-11
RAGHX returned −3.07% year to date and +9.31% over one year to Jun 2026. Over one year the fund trailed its Health Care Equity category average: $100 grew to $109, against $137 for the category. Volatility over the past 12 months was 17.28% a year. In the 12 months to Jun 2026 the fund lost a net $20.7M, and assets reached $91.70M.
RAGHX Growth of $100
What $100 invested in Virtus KAR Health Sciences Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.
| Period | RAGHX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $109 | $137 |
| 3 years (Jul 2023 – Jun 2026) | $37 | $138 |
| 5 years (Jul 2021 – Jun 2026) | $9 | $121 |
| Since data start (Jul 2019 – Jun 2026) | $13 | $182 |
RAGHX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −3.07% |
| 1 year | +9.31% |
3- and 5-year figures withheld: returns differ from sibling classes.
RAGHX Annual Returns
Calendar-year total returns of Virtus KAR Health Sciences Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | −3.07% |
| 2025 | +7.23% |
| 2024 | −50.46% |
| 2023 | −47.98% |
| 2022 | −55.26% |
| 2021 | −15.60% |
| 2020 | +13.63% |
| 2019 (Jul–Dec) | +11.85% |
RAGHX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −2.6% | +3.5% | −9.8% | −0.8% | +1.4% | +6.0% | — | — | — | — | — | — |
| 2025 | +5.5% | −1.0% | −5.6% | −2.3% | −2.7% | +1.5% | −3.2% | +3.3% | +0.6% | +4.8% | +8.9% | −1.7% |
| 2024 | −3.6% | −1.2% | −2.7% | −11.1% | −2.5% | −3.8% | −5.8% | −4.1% | −6.9% | −11.2% | −3.8% | −10.7% |
| 2023 | −2.8% | −10.6% | −2.8% | −4.1% | −10.5% | −0.3% | −5.3% | −6.0% | −10.8% | −11.3% | +1.1% | +1.2% |
| 2022 | −14.7% | −4.1% | −1.1% | −11.8% | −5.5% | −7.6% | −1.4% | −13.1% | −10.8% | +1.5% | +0.2% | −7.6% |
| 2021 | +1.8% | −0.2% | +1.7% | +4.8% | +1.0% | −1.5% | −1.5% | −3.1% | −9.2% | −1.7% | −10.0% | +2.3% |
| 2020 | −2.0% | −5.7% | −4.7% | +12.5% | +4.5% | −2.1% | +3.8% | +1.0% | −0.2% | −4.3% | +8.9% | +2.9% |
| 2019 | — | — | — | — | — | — | −1.3% | −0.6% | −2.1% | +5.2% | +5.8% | +4.7% |
RAGHX Risk
Risk measures from monthly returns over Jul 2025 – Jun 2026.
- 1-year volatility (annualised): 17.28%
- Best month: +8.95% (Nov 2025)
- Worst month: −9.83% (Mar 2026)
RAGHX Fund Flows
Monthly money in and out of Virtus KAR Health Sciences Fund, from SEC Form N-PORT.
- 12-month net flow: −$20.7M
- 12-month gross sales (incl. reinvestments): $2.4M
- Sales ÷ redemptions: 0.10×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $94K | $1.6M | −$1.5M |
| May 2026 | $12K | $933K | −$921K |
| Apr 2026 | $174K | $1.6M | −$1.4M |
| Mar 2026 | $44K | $1.7M | −$1.7M |
| Feb 2026 | $46K | $1.6M | −$1.5M |
| Jan 2026 | $1.2M | $2.8M | −$1.6M |
| Dec 2025 | $104K | $1.6M | −$1.5M |
| Nov 2025 | $188K | $1.3M | −$1.1M |
| Oct 2025 | $87K | $1.9M | −$1.8M |
| Sep 2025 | $201K | $4.3M | −$4.1M |
| Aug 2025 | $32K | $1.7M | −$1.7M |
| Jul 2025 | $132K | $2.0M | −$1.9M |
RAGHX Assets Under Management
Net assets of Virtus KAR Health Sciences Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $91.70M |
| 2026-03-31 | $89.76M |
| 2025-12-31 | $103.63M |
| 2025-09-30 | $96.52M |
| 2025-06-30 | $103.77M |
| 2025-03-31 | $111.78M |
| 2024-12-31 | $119.31M |
| 2024-09-30 | $141.35M |
| 2024-06-28 | $145.95M |
| 2024-03-28 | $151.31M |
| 2023-12-29 | $142.39M |
| 2023-09-29 | $138.26M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.